For research use only. Not for therapeutic Use.
| Catalog Number | R067917 |
| Synonyms | N-C12:0-NBD-CTH; N-C12:0-NBD-Globotriaosylceramide |
| Molecular Formula | C54H91N5O21 |
| Purity | ≥95% |
| Storage | Store at -20°C |
| Reference | <br>1. J. Kok et al. “Dihydroceramide Biology STRUCTURE-SPECIFIC METABOLISM AND INTRACELLULAR LOCALIZATION” Journal of BiologicalChemistry, Vol. 272 pp. 21128-21136, 1997<br>2. J. Hsu et al. “Enhanced endothelial delivery and biochemical effects of ?-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease” Journal ofControlled Release, doi:10.1016/j.jconrel.2010.10.031, 2010<br>3. J. E. Groener, B. J. Poorthuis, S. Kuiper, M. T. Helmond, C. E. Hollak, J. M. Aerts. “HPLC for simultaneous quantification of total ceramide,glucosylceramide, and ceramide trihexoside concentrations in plasma.” Clin Chem., Apr;53(4):742-7, 2007. Epub Mar 1 2007<br>4. K. Mills, A. Johnson, B. Winchester. “Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabrydisease by tandem mass spectrometry.” FEBS Lett., Mar 27;515(1-3):171-6, 2002<br>5. C. Menge, I. Stamm, M. Wuhrer, R. Geyer, L. H. Wieler, G. Baljer. “Globotriaosylceramide (Gb(3)/CD77) is synthesized and surface expressed bybovine lymphocytes upon activation in vitro.” Vet Immunol Immunopathol., Nov;83(1-2):19-36, 2001</br></br></br></br></br> |
